by delphic-admin | Jan 23, 2024 | North America
The US Food and Drug Administration (FDA) has issued instructions for reporting serious adverse events under the Modernization of Cosmetics Regulation Act (MoCRA). From 29 December, the statute compels industry to notify the agency about any case linked to...
by delphic-admin | Jan 23, 2024 | North America
The US Food and Drug Administration (FDA) has launched an online system for industry to provide personal care product listings required by the Modernization of Cosmetics Regulation Act (MoCRA). Available on 18 December, the Cosmetics Direct portal was developed...
by delphic-admin | Jan 23, 2024 | North America
The FDA finalised draft guidance released in August on registration and listing requirements for cosmetic facilities and products. The guidance includes a new draft appendix meant to answer queries about the entities and items covered under MoCRA. For instance, it...
by delphic-admin | Dec 1, 2023 | North America
The US Food and Drug Administration (FDA) has deferred to mid-2024 the enforcement of product listing requirements imposed by the Modernization of Cosmetics Registration Act (MOCRA). Industry now has another half-year – until 1 July – to fulfill these duties under the...
by delphic-admin | Sep 28, 2023 | North America
The United States FDA is currently developing systems and processes to enable companies to comply with the new MoCRA requirements, including the process to submit: Facility registrations Product listings The system should be available in October 2023 On 7 August 2023,...